Clinical benign prostatic hyperplasia (BPH) is one of the most common diseases in ageing
men and the most common cause of lower urinary tract symptoms (LUTS). The prevalence of …

CONTEXT: Metabolic syndrome (MetS), a cluster of several metabolic abnormalities with a
high socioeconomic cost, is considered a worldwide epidemic. Recent epidemiologic and …

Benign prostatic hyperplasia (BPH) is a histological diagnosis associated with unregulated
proliferation of connective tissue, smooth muscle and glandular epithelium. BPH may …

The epidemiology of benign prostatic hyperplasia (BPH) and male lower urinary tract
symptoms (LUTS) has evolved considerably during the past several years. The term LUTS …

Lower urinary tract symptoms (LUTS)—constituting a spectrum disorder that encompasses
weak stream, nocturia, and sensations of incomplete emptying and intermittent or hesitant …

The current epidemiologic evidence suggests that men with type 2 diabetes mellitus may be
at lower risk of developing prostate cancer, but little is known about its association with stage …

Lifestyle factors present a novel opportunity for the prevention and treatment of benign
prostatic hyperplasia and lower urinary tract symptoms. Although clinical trials of lifestyle …

With diabetes mellitus (DM) reaching epidemic proportions, the identification of voiding
dysfunction as a common and burdensome complication of this disease is critical. Research …

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities related to central
adiposity and insulin resistance. Its importance is increasingly recognized as it associates …

As men age, a growing number develop benign prostatic hyperplasia (BPH). According to
previous research, diabetes may be a risk factor. Pyruvate dehydrogenase kinase 4 (PDK4) …